Mindset Pharma Announces Further Preclinical Results Demonstrating Strong Efficacy and Improved Safety Profile for its 5-MeO-DMT-Inspired Drug Candidate, MSP-4018
TORONTO, Sept. 09, 2021 (GLOBE NEWSWIRE) — Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurological and psychiatric disorders with unmet medical needs, today announced that preclinical proof-of-concept data comparing its clinical candidate, MSP-4018, against 5-MeO-DMT further demonstrated strong efficacy and an improved safety profile as a next generation psychedelic medicine.
“Given the strong preclinical efficacy and safety data in support of MSP-4018, combined with our expedited manufacturing process, we believe our Family 4 clinical candidate has the potential to provide a safer and more scalable therapeutic alternative to first-generation 5-MeO-DMT. We believe this preclinical data will enable us to quickly advance this novel compound into human clinical trials,” said James Lanthier, CEO of Mindset.
Click here to see full press release.
NO INVESTMENT ADVICE IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of Mindset Pharma (OTC:MSSTF). Wasatch Investment Network is an investment newsletter being advertised herein. This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to buy or sell, or as a solicitation to buy or sell, any securities. In an effort to enhance public awareness of (OTC:MSSTF), provided advertising agencies with a total budget of approximately one $1,606,579 dollars to cover the costs associated with creating, printing and distribution of this advertisement August 02, 2021 – October 30, 2021. Payor has represented to advertising agencies in writing that this advertising campaign is funded by OTC:MSSTF, to be profiled in this advertisement after Wasatch Investment Network conducted an investigation of the company and its management. Wasatch Investment Network was paid thirty-five thousand dollars as a research fee. In addition, Wasatch Investment Network may receive subscription revenue in the future from new subscribers as a result of this advertisement. The advertising agencies will retain any excess sums after all expenses are paid. During the period of time this advertisement is being disseminated, neither Wasatch Investment Network, the advertising agencies, nor their respective officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated thereunder) and will, receive or sell such securities of Mindset Pharma. for not less than 90 days following the conclusion of this advertising campaign. The Payor has represented in writing to Wasatch Investment Network and the advertising agencies that neither it nor its officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated thereunder) owns or beneficially owns any securities of the OTC:MSSTF or will purchase, receive, or sell any such securities for not less than 90 days following the conclusion of this advertising campaign. If successful, this advertisement will increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of OTC:MSSTF, increased trading volume, and possibly an increased share price of OTC:MSSTF securities, which may be temporary. This advertisement, the advertising agencies and Wasatch Investment Network do not purport to provide a complete analysis of OTC:MSSTF’s financial position. They are not, and do not purport to be, broker-dealers or registered investment advisors. This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a registered broker-dealer or registered investment advisor or doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell and only after reviewing the financial statements and other pertinent publicly-available information about OTC:MSSTF and its industry. Further, readers are specifically urged to read and carefully consider the Risk Factors identified and discussed in OTC:MSSTF SEC filings. Investing in microcap securities such as OTC:MSSTF is speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the advertising agencies and Wasatch Investment Network cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions. This advertisement contains forward-looking statements, including statements regarding expected continual growth of OTC:MSSTF and/or their industry. The advertising agencies and Wasatch Investment Network note that statements contained herein that look forward in time, which include everything other that historical information, involve risks and uncertainties that may affect OTC:MSSTF actual results of operations. Factors that could cause actual results to differ include the size and growth of the market for OTC:MSSTF products and/or services, the company’s ability to fund its capital requirements in the near term and long term, Federal and state regulatory issues pricing pressures, etc. Wasatch Investment Network is the publisher’s trademark. All trademarks used in this advertisement other than Wasatch Investment Network are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. The advertising agencies and Wasatch Investment Network are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks